Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

NCT00014495 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

BIOLOGICAL: filgrastim
DRUG: cytarabine
RADIATION: bismuth Bi213 monoclonal antibody M195

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]